| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/16/2003 | CN1411467A Compounds and use thereof to modify transport across cell membranes |
| 04/16/2003 | CN1411461A Thienopyridine derivatives and their preparing process and use |
| 04/16/2003 | CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 04/16/2003 | CN1411459A Compound and method for treatment of pain |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411457A Substituted pyrroles |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/16/2003 | CN1411453A Trans olefinic glucokinase activators |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411442A Farnesyl transferase inhibitors |
| 04/16/2003 | CN1411441A Farnesyl protein transferase inhibitors |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1411386A Treatment of subnormal bone mineral density |
| 04/16/2003 | CN1411379A Preventives or remedies for arrhythmia |
| 04/16/2003 | CN1411376A Novel helicobacter pylori-binding substances and use thereof |
| 04/16/2003 | CN1411374A Substituted piperazine and piperidine calcium channel blockers |
| 04/16/2003 | CN1411365A Cosmetic compositions containing mulberry extract and retinoids |
| 04/16/2003 | CN1411347A Composition for improving proliferative response during adapation of gastrointestinal tract and use in short bowel syndrome |
| 04/16/2003 | CN1410093A Medicine for treating cyst |
| 04/16/2003 | CN1410090A Liuhexinpi oil preparation, its formulation and preparation technology |
| 04/16/2003 | CN1410085A Ripening agent and eliminating agent for abnormal black balliary matter and its preparation method |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/16/2003 | CN1410057A Special inhibitor for ruminant urease |
| 04/16/2003 | CN1105781C Method for preparing rare ginsengoside using enzymatic method to modify ginsengoside glycoside |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105716C Benzimidazole derivatives with antihistaminic activity |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/16/2003 | CN1105577C Parathyroid hormone and raloxifene for increasing bone mass |
| 04/16/2003 | CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products |
| 04/15/2003 | US6548715 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine |
| 04/15/2003 | US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548665 Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof |
| 04/15/2003 | US6548653 Erythropoietin analog-human serum albumin fusion |
| 04/15/2003 | US6548641 PTP 1D: a novel protein tyrosine phosphatase |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548548 Cardiovascular disorders; anticholesterol agents |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548546 HIV integrase inhibitors |
| 04/15/2003 | US6548540 Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump |
| 04/15/2003 | US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548516 (NMDA=N-methyl-D-aspartate); where the heteroaryl is 3H-benzoxazol-2-one, 3H-benzothiazol-2-one, 3H-benzimidazol-2-one or indolin-2-one; excitatory amino acid antagonists for combating neurodegenerative disorders |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548513 (E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(methyl -sulfonyl)amino)pyrimidin-5-yl)-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or salt, stabilized by an inorganic salt having a multivalent cation, excluding synthetic hydrotalcite |
| 04/15/2003 | US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548497 Methods of reducing non-inflammatory pain |
| 04/15/2003 | US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives |
| 04/15/2003 | US6548494 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | US6548490 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 04/15/2003 | US6548488 Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
| 04/15/2003 | US6548484 An amidation product of ribosyl or glucosyl saccharide and a dopamine or derivative ( forms a amide through amine and carboxylic group); useful for treating neurological diseases including Parkinson's and related diseases |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/15/2003 | US6548480 Reacting a phosphorylated derivatives with a dipeptide to displace halogen atom of phosphorylated derivative, deprotecting to form a phosphonic acid derivative; neutral endopeptidase and angiotensin converting enzyme inhibitor |
| 04/15/2003 | US6548479 Fused bicyclic peptides are administered to an animal to inhibit the proliferation of CD4 T-cells |
| 04/15/2003 | US6548476 Dimeric inhibitors of influenza neuraminidase |
| 04/15/2003 | US6548284 Membrane-bound metalloprotease and soluble secreted form thereof |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548066 Inducing antibodies; antitumor agent |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | US6548061 Repair central nervous system damage; kit containing complement fixing antibodies |
| 04/15/2003 | US6548041 Diagnosis, therapy of central nervous system disorders |
| 04/15/2003 | US6547769 Catheter apparatus with weeping tip and method of use |
| 04/15/2003 | CA2278988C An efficient synthesis of furan sulfonamide compounds useful in the synthesis of new il-1 inhibitors |
| 04/15/2003 | CA2261099C Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an hmg-coa-reductase inhibitor |
| 04/15/2003 | CA2097715C Indan derivatives |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/15/2003 | CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/15/2003 | CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors |
| 04/15/2003 | CA2048242C 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors |
| 04/11/2003 | WO2002032899A1 Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 04/11/2003 | WO2002031131A1 Novel pla1 |
| 04/11/2003 | WO2002030928A1 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| 04/11/2003 | CA2425845A1 Novel pla1 |
| 04/10/2003 | WO2003029467A1 Candidate protein for novel cell polarization factor and polynucleotide encoding the protein |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029463A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029462A1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029434A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 04/10/2003 | WO2003029428A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029420A2 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | WO2003029418A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | WO2003029295A1 Human tissue factor antibodies |
| 04/10/2003 | WO2003029292A2 Gene regulatory peptides |
| 04/10/2003 | WO2003029287A1 Ferroportin-1 mutant |
| 04/10/2003 | WO2003029276A2 Copolymers for suppression of autoimmune diseases, and methods of use |